Nocion Therapeutics
PrivateLast Round
Early Stage
VC
Mar 13, 2026
Est. Valuation
$125M
Total Funding Raised
$166M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nocion Therapeutics is a biopharmaceutical company developing a new class of small molecule charged sodium channel blockers, called nocions, to treat conditions such as chronic cough, pain, and itch.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nocion Therapeutics Comparables
Compare Nocion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeRRe Therapeutics | 82% | |
| Axalbion | 80% | |
| GSK plc | 78% |
Nocion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 13, 2026 | ||||
| Series B Extension | Jan 7, 2026 | ||||
| Series B | Mar 4, 2024 | ||||
| Series A | Jan 25, 2021 | ||||
| Series A | Apr 17, 2019 | ||||
Seed | Jul 10, 2018 |
Nocion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B, Series B Extension, Series A |
| Mass General Brigham Innovation | Series B Extension, Series B, Series A |
| Mass General Brigham Ventures | Series B Extension |
| Osage University Partners | Series B, Series B Extension |
| BioInnovation Capital | Series B, Series A, Series B Extension |
| Monograph Capital | Series B, Series B Extension |
| Canaan Partners | Series B, Seed, Series A, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 54% MoM.
- Jan 7, 2026
$23M raised in Series B Extension round.
Nocion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nocion Therapeutics's valuation, stock price, and market status.
Is Nocion Therapeutics a public or private company?
Nocion Therapeutics is a private company.
What is the current stock price of Nocion Therapeutics?
Nocion Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Nocion Therapeutics worth (valuation)?
Valuation information for Nocion Therapeutics is not publicly available.
Can I buy Nocion Therapeutics stock?
Nocion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nocion Therapeutics's last funding round?
Nocion Therapeutics's most recent funding round was Early Stage VC on March 13, 2026.
Who are the main investors in Nocion Therapeutics?
Key investors in Nocion Therapeutics include F-Prime Capital, Monograph Capital, Arkin Bio Capital.
Will Nocion Therapeutics IPO soon?
No public IPO plans have been announced for Nocion Therapeutics.
How can I track Nocion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nocion Therapeutics's secondary market activity and sign up for updates.